Radial to Visceral (R2V™) intervention brings various benefits over Transfemoral Artery Access (TFA), including reduced bleeding complications, easy access site management, improved patient satisfaction and the opportunity for same day discharge. Terumo offers various access devices and embolic agents for R2V™. 1-7
- Amin A, et al. Costs associated with access site and same-day discharge among Medicare beneficiaries undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2017;10(4):342-51.
- Schussler JM. Effectiveness and safety of transradial artery access for cardiac catheterization. Proc (Bayl Univ Med Cent). 2011; 24(3):205-209.
- Marso S. et al. Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention. JAMA. 2010;303(21):2156-2164.
- Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13(5):354-362.
- Valgimigli M, et al. MATRIX Trial. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomized multicenter trial. Lancet. 2015;385:2465-76.
- Rathore S. Impact of Length and Hydrophilic Coating of the Introducer Sheath on Radial Artery Spasm During Transradial Coronary Intervention A Randomized Study. JACC Cardiovasc Interv. 2010;3(5):475-83.